Sequential anti-CD19 therapy

The present invention relates to therapeutic compositions and methods for the sequential treatment of cancer in human patients using therapeutic agents that bind to human CD1g. 本发明涉及用于使用结合至人CD1g的治疗剂序贯治疗人患者的癌症的治疗性组合物和方法。

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ENDELL JAN, FRICKER SEBASTIEN
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to therapeutic compositions and methods for the sequential treatment of cancer in human patients using therapeutic agents that bind to human CD1g. 本发明涉及用于使用结合至人CD1g的治疗剂序贯治疗人患者的癌症的治疗性组合物和方法。